We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Partial Surgery Spares Kidney Function

By HospiMedica staff writers
Posted on 10 Mar 2006
A new study finds that a large percentage of patients with small kidney tumors have their entire kidney removed as treatment, even though they may be suitable for surgery that removes only the cancer and spares the rest of the normal kidney, called partial nephrectomy.

Researchers at the University of Michigan Comprehensive Cancer Center (Ann Arbor, USA) looked at data concerning 14,647 people treated from 1988 to 2001 for kidney cancers less than 7 cm in size. More...
During this 13-year interval, only 9.6% of patients were treated with partial nephrectomy, while the remaining 90% had their entire kidney removed. The results of the study appear in the March 2006 issue of the Journal of Urology.

The researchers found that for tumors smaller than 4 cm, removing only the tumor and a small margin of healthy tissue is just as effective at controlling the cancer as removing the entire kidney. However, not everyone with kidney cancer is eligible for partial nephrectomy. While tumor size is a major indicator of eligibility, other factors that should generally be considered include the location of the tumor within the kidney; overall kidney function; the presence of other medical conditions, including diabetes, high blood pressure, and kidney stones; and patient preference.

"For most surgeons, myself included, partial nephrectomy, whether open or laparoscopic, is likely to be a more difficult operation than removing the entire kidney. Many surgeons are able to take the whole kidney out laparoscopically but are less experienced performing partial nephrectomy laparoscopically,” said study author David Miller, M.D., clinical lecturer in urology at the University of Michigan Medical School, offering one explanation for the low prevalence of partial nephrectomy.






Related Links:
University of Michigan Comprehensive Cancer Center

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.